Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

CG1 Non-renounceable Pro-rata Entitlement Offer

by admin August 22, 2025
August 22, 2025
CG1 Non-renounceable Pro-rata Entitlement Offer

Carbonxt Group (CG1:AU) has announced CG1 non-renounceable pro-rata entitlement offer

Download the PDF here.

This post appeared first on investingnews.com

previous post
How a ship that glides like a pelican could change travel and defense
next post
Top 5 Copper Reserves by Country

Related Posts

Finlay Minerals Announces Grant of Stock Options

December 11, 2025

Silver Miners Deliver Record Q2 Earnings as Price...

August 20, 2025

Denison Mines Moves Closer to Federal Approval for...

March 1, 2025

Crypto Market Recap: SEC Dismisses Coinbase Case, Debuts...

February 22, 2025

Guy Le Page: Copper, Uranium Top of Mind,...

March 20, 2025

Robotics Stocks: 10 Biggest Companies in 2025

September 16, 2025

Pinnacle Increases Non-Brokered Private Placement

July 26, 2025

New Purpose ETFs Give Canadian Investors Access to...

February 21, 2025

Greenland Tanbreez Project Maiden Drill Results

January 25, 2025

Funding of up to C$1.3 million through Canada’s...

February 7, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved